Erwin De Genst
AstraZeneca (Brazil)(BR)AstraZeneca (Germany)(DE)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Glycosylation and Glycoproteins Research, Protein Structure and Dynamics, Escherichia coli research studies, Parkinson's Disease Mechanisms and Treatments
Most-Cited Works
- → Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies(2006)658 cited
- → Camelid immunoglobulins and nanobody technology(2008)534 cited
- → Receptor binding studies disclose a novel class of high‐affinity inhibitors of the Escherichia coli FimH adhesin(2004)437 cited
- → Antibody repertoire development in camelids(2005)184 cited
- → Molecular Basis of Gyrase Poisoning by the Addiction Toxin CcdB(2005)144 cited
- → Silk micrococoons for protein stabilisation and molecular encapsulation(2017)133 cited
- → Wnt3a binds to several sFRPs in the nanomolar range(2007)